9 Recruiting Castration-Resistant Prostate Carcinoma Phase 1 Clinical Trials
Active phase 1 studies for castration-resistant prostate carcinoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Castration-Resistant Prostate Carcinoma studiesPhase 1 Studies for Castration-Resistant Prostate Carcinoma
🔵 Active, Not Recruiting Phase1
Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate Cancer
📍 University of California Davis Comprehensive Cancer Center — Sacramento, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1
Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer
📍 Roswell Park Cancer Institute — Buffalo, New York
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis
📍 UC San Diego Moores Cancer Center — La Jolla, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1
PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate Cancer
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer
📍 OHSU Knight Cancer Institute — Portland, Oregon
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔ 🟢 Recruiting Phase1
Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy
📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔ 🟢 Recruiting Phase1
PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
📍 Rush University — Chicago, Illinois
View Study & Checklist ➔